You are here

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset

http://dx.doi.org/10.1136/jitc-2021-003385corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Veneziani I, Alicata C, Pelosi A, et al. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset. J Immunother Cancer 2022;10:e003385. doi:10.1136/jitc-2021-003385

    This article has been corrected since it was first published. An error with figure 2 and the supplemental material has been amended.